48.1 F
New York
Monday, November 30, 2020

Abbott [NYSE: ABT] Receives FDA Approval For 15 Minute COVID-19 Test

Must read

Tesla [NASDAQ: TSLA] Recalls 9537 SUV’s Because Of Manufacturing Issues

Tesla Inc. has released safety recall orders for more than 9500 of its vehicle in the United States. The vehicles include Model Xs...

Northrop [NYSE:NOC] awarded a deal of $4.8B for Global Hawk Aircraft

Northrop Gruman Corp. has been awarded a deal to perform development, transformation, retrofit, and sustenance activities for the Global Hawk Program. This deal...

Athene Enters Into An Agreement With Hertz To Buy Donlen Corp.

Athene Holdings ltd. entered into a deal to buy Donlen corporation from Hertz Global Holdings Inc. Hertz's fully own Donlen Corporation. The stock...

Verizon [NYSE: VZ] Announced to acquire Tracfone for $6.25 billion.

Verizon Communication Inc. declared that it penned down a deal with America Movil to purchase Tracfone for $6.25B. The companies came to terms...

Abbott Laboratories [NYSE: ABT] disclosed it has received the emergency use authorization of FDA for the COVID-19 test. The new test can deliver results in only 15 minutes.

BinaxNOWTM is a fast and rapid test for the detection of COVID-19 infection. BinaxNOWTM is highly portable and affordable. Abbott has decided to sell this test is $5.

Shares of Abbott soared 0.70%, or up +0.72 during the trading of Wednesday. It has a closing price of $103.19. ABT has a day low and high range of $101.26-$103.29, respectively.

It had recorded the trading volume of 2.97 million as compared to the average volume of 5.05 million. If we look at its profitability, it has return on assets (ROA) of 4.60%, return on investment (ROI) of 8.20% and return on equity (ROE) of 10.10%.

Abbott Laboratories has a Gross Margin of 57.70%, a Profit Margin of 9.90%, and an Operating Margin of 12.80%. Turing our focus on its liquidity, its current ratio is 1.60.

Similarly, its quick ratio is 1.10, and the debt to equity ratio is 0.64. This company has a long term to equity ratio is 0.59.

Furthermore, ABT has reported the sales of 31.44 billion and has a market capitalization of 181.33 billion.

In the past 52-weeks of trading, this company’s stocks have changed between the low range of $61.61 and a high range of $103.23.

Hence, its shares have increased by 67.49%, and decreased by 0.04% from its 52-weeks low and high range, respectively. Now if we look at its new rapid test, it is paired up with mobile app NAVICATM.

Furthermore, it worked like a secure digital boarding pass that can be scanned to enter organizations and the other places where people gather.

Data submitted to FDA disclosed that the BinaxNOW COVID-19 Ag Card exhibited a sensitivity of 97.1% (positive percent agreement).

It also showed the specificity of 98.5% (negative percent agreement) in patients with COVID-19 by health carer within 7 days of symptoms onset.

More articles

Latest article

ViacomCBS [NASDAQ: VIAC] Agreed To Sell Simon And Schuster For $2.175 Billion In Cash

ViacomCBS Inc. declared that it entered into an agreement with Penguin Random House LCC to sell Simon and Schuster. It will be sold...

IBM [NYSE: IBM] Plans To Cut Down 20% Of Its Workforce

International business machines Corp. declared that the company is preparing to cut down 10,000 jobs in Europe which makes it’s 20% of the...

Ford [NYSE: F ] Booked Ultra-Cold Freezers To Ensure Autoworkers Access To The Covid-19 Vaccine

Ford Motors Co. revealed recently that to stock Pfizer Inc Covid-19 vaccine securely, it has requested 12 of the ultra-cold freezer. The automaker...

Transdigm [NYSE: TDG] Enters Into An Agreement To Buy Cobham Aero Connectivity

Transdigm group incorporation , the global aircraft component manufacturer and provider declared the acquisition of Cobham Aero Connectivity, the top supplier of antennas and...

LCI Industries’ [NYSE: LCII] Subsidiary Lippert Components Acquires Challenger Door

LCI Industries has revealed that its unit Lippert Components has completed the acquisition of Challenger Door, Inc. This acquisition will provide the opportunity...

Blackstone Group [NYSE: BX] Finalizes Recapitalization Of BioMed Realty

The Blackstone Group Inc. has disclosed today that Blackstone Real Estate Partners VIII L.P.  has executed the deal related to BioMed Realty. The...

Pfizer-BioNTech’s COVID19 Vaccine Candidate Acheive 95% Success

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have disclosed Wednesday that their COVID-19 vaccine candidate, BNT162b2, has shown a 95% efficacy rate...

Scienjoy [NASDAQ: SJ] Inks Agreement With China Mobile

Scienjoy Holdings Corporation has revealed today that it has inked a cooperative agreement with China Mobile on November 1, 2020. The company disclosed...